Načítá se...
Usability and Robustness of the Wixela Inhub Dry Powder Inhaler
Background: Wixela Inhub is a generic version of Advair Diskus recently approved by the U.S. Food and Drug Administration. The Inhub inhaler delivers fluticasone propionate (FP)/salmeterol in a dry powder formulation. The goals of our studies were to demonstrate that the Inhub inhaler can be used by...
Uloženo v:
| Vydáno v: | J Aerosol Med Pulm Drug Deliv |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mary Ann Liebert, Inc., publishers
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8060712/ https://ncbi.nlm.nih.gov/pubmed/32865454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2020.1603 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|